You are here

Delays in shipping: Due to current delays in our warehouse shipping services, please expect longer than usual delivery times for any print book and journal orders. If you need access to content immediately, please consider ordering a digital product. We apologize for any inconvenience and thank you for your patience.

If you need further assistance please visit our Contact us page for further information. 

Multiple Sclerosis Journal – Experimental, Translational and Clinical


eISSN: 20552173 | ISSN: 20552173 | Current volume: 10 | Current issue: 1 Frequency: Quarterly

Journal Highlights

  • Now discoverable in PubMedCentral.
  • The open access companion journal to Multiple Sclerosis Journal.
  • Articles received more than 130,000 full-text downloads in 2022.

Multiple Sclerosis Journal – Experimental, Translational and Clinical is an international, peer reviewed, open access publication that augments the potential to publish across the broad spectrum of experimental, translational and clinical topics in Multiple Sclerosis. For more information on the journal please visit the aims and scope tab.

As an open access publication, all articles are freely available online immediately upon publication. All articles are rigorously peer-reviewed, and brought to publication as rapidly as possible.

The journal is also a member of the Committee on Publication Ethics (COPE).

Submission information

Submit your manuscript today at https://mc.manuscriptcentral.com/msj-etc.

Please see the submission guidelines tab for more information on how to format your manuscript.

Open access information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence.

The APC for this journal is 2650 USD.

Members of the American Committee for Treatment and Research in Multiple Sclerosis, the European Committee for Treatment and Research in Multiple Sclerosis, the Latin American Committee for Treatment and Research in Multiple Sclerosis, the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis or Rehabilitation in Multiple Sclerosis will receive a 75% discount on the APC.

The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is also subject to taxes where applicable. Please see further details here.

Multiple Sclerosis Journal – Experimental, Translational and Clinical is an international, peer reviewed, open access publication that augments the potential to publish across the broad spectrum of experimental, translational and clinical topics in Multiple Sclerosis. It facilitates the rapid publication of high quality papers in:

  • Emerging observations with translational potential not yet realized.
  • Early validation of clinical outcome metrics.
  • Pilot trials which may stimulate therapeutic innovation.
  • Geographic focus which validate and add to existing studies.
  • High specialized areas of experimental, translational and clinical research.
Editors
Georgina Arrambide Hospital Vall d’Hebron, Spain
Simon Broadley Griffith University, Australia
Shiv Saidha Johns Hopkins University, USA
Consulting Editors
Jeffrey Cohen Cleveland Clinic, USA
Ho Jin Kim Research Institute and Hospital of National Cancer Center, Korea
Maria Pia Amato (ECTRIMS President) Department of NEUROFARBA, University of Florence, Italy
Jaume Sastre-Garriga Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Spain
Alan J Thompson University College London, UK
Associate Editors
Jeff Cohen (ACTRIMS President) Cleveland Clinic, USA
Kazuo Fujihara (President PACTRIMS) Fukushima Medical University School of Medicine and Southern TOHOKU Research Institute for Neuroscience, Japan
Fernando Humay Diaz de Bedoya(LACTRIMS President) Institute of Tropical Medicine, Paraguay
Maria Pia Amato (ECTRIMS President) Department of NEUROFARBA, University of Florence, Italy
Social Media Editor
Wallace Brownlee University College London, UK
Editorial Board
Jack Antel Montreal Neurologic Hospital, Canada
Nathalie Arbour Université de Montréal, Canada
Peter Arnett Penn State University, USA
Sergio Baranzini University of California San Francisco, USA
Frederik Barkhof Vrije Universiteit, The Netherlands & University College London, UK
Ralph Benedict University of Buffalo, USA
Jeff Bennett University of Colorado Denver, USA
Simon Broadley Griffith University, Australia
Peter A. Calabresi Johns Hopkins, USA
Nancy Chiaravalloti Kessler Foundation, USA
Olga Ciccarelli UCL Institute of Neurology, UK
Manuel Comabella Centre d'Esclerosi Multiple de Catalunya, Spain
Giancarlo Comi Vita-Salute San Raffaele University and Scientific Institute, Italy
Fiona Costello University of Calgary, Canada
Gary Cutter University of Alabama at Birmingham, USA
Ulrik Dalgas Aarhus University, Denmark
Philip De Jager Columbia University, USA
Gabriele DeLuca University of Oxford, UK
Suhayl Dhib-Jalbut (President ACTRIMS) Rutgers University, New Jersey, USA
Ranjan Dutta Cleveland Clinic, USA
Anthony Feinstein University of Toronto, Canada
Peter Feys Hasselt University, Belgium
Robert Fox Cleveland Clinic, USA
Mark Freedman The Ottawa Hospital-General Campus, Canada
Jennifer Freeman University of Plymouth, UK
Stefan Gold Clinical Neuroscience and Immunology, Berlin, Germany
Eva Havrdova Charles University, Prague, Czech Republic
Hanneke Hulst VU MS Centre Amsterdam, Netherlands
Matilde Inglese Mount Sinai School of Medicine, USA
Noriko Isobe Kyushu University, Japan
Tomas Kalincik University of Melbourne, Australia
Joep Killestein VU University Medical Center, Amsterdam, Netherlands
Alexander Klistorner Macquarie University, Sydney Australia
Daphne Kos University of Leuven, Belgium
Tanja Kuhlmann University of Münster, Germany
Catherine Lubetzki Salpetriere Hospital, France
Gianvito Martino San Raffaele Scientific Institute, Milan, Italy
Veronique Miron University of Edinburgh, UK
Xavier Montalban Vall d'Hebron University Hospital, Barcelona, Spain
Dan Ontaneda Cleveland Clinic Lerner College of Medicine, Mellen Center for Multiple Sclerosis, USA
Maria Pia Amato (ECTRIMS President) Department of NEUROFARBA, University of Florence, Italy
Anne-Louise Ponsonby Murdoch Children’s Research Institute, University of Melbourne, Australia
Danny Reich National Institutes of Health Translational Neuroradiology Unit, USA
Maria Rocca San Raffaele Hospital, Italy
Jaume Sastre-Garriga Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Spain
Menno Schooneim Amsterdam University Medical Centres, the Netherlands
Allessandra Solari IRCCS Carlo Besta Neurological Institute Foundation, Italy
Maria Pia Sormani University of Genoa, Italy
Ahmed Toosy University College London, UK
Carmen Tur University College London, London, UK
Ann Yeh The Hospital for Sick Children (SickKids), Canada
  • Clarivate Analytics: Emerging Sources Citation Index (ESCI)
  • ProQuest
  • PubMed Central (PMC)
  • Scopus

Manuscript submission guidelines can be accessed on Sage Journals.